Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	345	518	125	589	2,339	4,749
Market Cap Growth	99.95%	315.99%	-78.86%	-74.81%	-50.75%	70.50%
Enterprise Value	868	1,044	917	1,414	2,824	5,255
Last Close Price	6.31	9.56	2.40	11.81	43.47	89.60
PE Ratio	-	-	-	-	10.65	15.53
Forward PE	10.07	-	-	51.15	7.19	9.53
PS Ratio	0.35	0.50	0.12	0.53	1.32	3.01
PB Ratio	0.62	1.07	0.19	0.43	1.45	3.28
P/TBV Ratio	5.11	-	1.51	1.34	2.99	9.18
P/FCF Ratio	3.65	14.47	-	-	24.34	12.02
P/OCF Ratio	3.13	8.82	-	-	7.30	8.85
PEG Ratio	-	-	-	11.76	0.21	0.68
EV/Sales Ratio	0.90	1.00	0.87	1.26	1.59	3.33
EV/EBITDA Ratio	14.05	19.55	-	90.08	5.60	8.63
EV/EBIT Ratio	-	-	-	-	7.32	10.53
EV/FCF Ratio	9.20	29.17	-	-	29.39	13.30
Debt / Equity Ratio	1.22	1.40	1.35	1.03	0.54	0.64
Debt / EBITDA Ratio	10.89	12.66	-	90.85	1.72	1.50
Debt / FCF Ratio	7.13	18.89	-	-	9.13	2.34
Asset Turnover	0.60	0.65	0.42	0.37	0.61	0.61
Inventory Turnover	1.89	2.09	2.03	1.85	3.01	2.70
Quick Ratio	3.15	1.56	0.47	0.66	2.29	2.22
Current Ratio	6.32	3.69	1.04	0.99	3.40	3.11
Return on Equity (ROE)	-21.63%	-33.67%	-74.67%	-14.11%	14.35%	24.12%
Return on Assets (ROA)	-1.61%	-2.03%	-4.21%	-2.23%	8.26%	11.98%
Return on Capital (ROIC)	-1.85%	-2.43%	-4.84%	-2.58%	9.93%	14.52%
Return on Capital Employed (ROCE)	-	-	-	-	14.90%	20.00%
Earnings Yield	-38.18%	-36.80%	-610.73%	-35.91%	9.39%	6.44%
FCF Yield	27.39%	6.91%	-207.11%	-25.44%	4.11%	8.32%
Buyback Yield / Dilution	-3.58%	-3.52%	-2.20%	7.39%	-0.56%	-2.67%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q